Atlantic-Pacific Capital, an independent global placement agent for alternative investment funds and direct private placements, has announced the oversubscribed final closing of New Cap
Atlantic-Pacific Capital, an independent global placement agent for alternative investment funds and direct private placements, has announced the oversubscribed final closing of New Capital Partners Private Equity Fund II with USD140m of capital commitments.
Atlantic-Pacific Capital was the exclusive global placement agent for the fund.
‘We would like to congratulate the New Capital Partners team,’ says Stephen Salyer, a principal at Atlantic-Pacific Capital (pictured). ‘Their exceptional track record and refreshing strategy proved to attract positive attention in a strenuous fundraising environment. We look forward to continuing our relationship with the team and wish them success as they execute their strategy.’
Based in Birmingham, Alabama and with offices in Dallas, New Capital Partners invests in micro and lower middle-market high growth companies in the healthcare, financial services and business services sectors primarily located in the underserved markets of the south-eastern US and Texas.
The inaugural New Capital Partners fund invested in ten portfolio companies and has realised two investments including HospiScript Services, a provider of pharmacy services to the Hospice industry, and Awarix, a provider of enterprise patient care visibility solutions for hospitals. Its portfolio also includes senior care organisation Senior Whole Health.
With offices in North America, Europe and Asia, Atlantic-Pacific Capital is a global placement agent solely dedicated to raising capital for alternative investment funds and direct private placement transactions. Typical projects include private equity, real estate and hedge fund placements, as well as private placement financings in support of acquisitions, buy-outs and growth capital transactions.
